Current studies in biotherapy of tumor

Biotherapy included LAK, interferon and immuno RNA.

生物疗法包括LAK细胞和干扰素、免疫核糖核酸。

Objective Increasing data recently showed that anti tumor vaccine had become an important biotherapy for cancer.

肿瘤疫苗是利用肿瘤抗原激发机体自身的免疫保护机制达到防治肿瘤的目的，近来肿瘤疫苗已发展成为一种重要的肿瘤生物治疗手段。

Discussion of Anaphylaxis Mechanism in the Biotherapy Treatment for Tumor

肿瘤生物治疗中过敏反应机制的探讨

Objective: To investigate the relation between methods on biotherapy for nasopharyngeal carcinoma and their curative effect.

前言：目的：探讨鼻咽癌生物治疗途径与疗效的关系。

The highlight of current cancer biotherapy& development of cellular, molecular targeted new agents

肿瘤生物治疗的新热点&细胞、分子靶向性药物的发展

Biotherapy in the prevention of postoperative recurrence of bladder cancer

生物疗法预防膀胱癌术后复发

Clinical Study of Biotherapy in Patient with Malignant Glioma of the Brain

人脑恶性胶质瘤生物治疗的临床研究鼠脑胶质瘤近距离放疗的实验研究脑胶质瘤的转移

One strategy for targeted cancer biotherapy is to utilize recombinant immunotoxins.

利用免疫毒素进行导向治疗是生物治疗的一个重要途径。

The development of biotherapy is in recent years, which is named the fourth treatment of malignant tumors.

生物治疗被称为治疗恶性肿瘤的第4种方法，近二十年来发展相当迅速，尤以基因工程改造的病毒为突出，E1B缺失腺病毒即是其中之一。

The Influence of Chemotherapeutic Dosage to Tumor Chemotherapy Linked with Biotherapy

化疗剂量对肿瘤化疗后衔接生物治疗的影响

Potential application of nano-materials on tumor biotherapy

纳米材料在肿瘤生物治疗中的潜在应用

Advance in research of proliferation and activation of immune cells in vitro for biotherapy of cancer

肿瘤生物治疗中免疫活性细胞体外增殖活化的研究进展

Conclusion Biotherapy/ biochemotherapy following surgery may significantly improve survival in patients with malignant melanoma.

结论恶性黑色素瘤患者术后给予生物治疗和生物化学治疗可明显延长生存时间。

To study on enhancement of the effect of biotherapy to ovarian carcinoma: A new method for treatment of cancer.

目的：提高治疗卵巢癌的疗效，探讨新的肿瘤生物治疗方法。

An experimental study on the anti tumor biotherapy of activated bone marrow

激活骨髓抗肿瘤生物效应的实验研究

Clinical Analysis of Efficacy Preventing Brain Metastases Treated with Temozolomide and Biotherapy in Malignant Melanoma

替莫唑胺联合生物疗法预防晚期黑色素瘤脑转移临床分析

The immunotherapy using Dendritic cells is one of the main direction for tumor biotherapy.

应用抗原提呈细胞-树突状细胞为中心的免疫治疗，是肿瘤生物学治疗的主要方向之一。

Most of biotherapy methods are the study of tumor immune gene therapy on the principle of improving host immune response.

目前的免疫基因治疗研究又多集中于细胞因子基因治疗。

Therefore, biotherapy strategy targeting these transcription factors may provide effective approaches for tumor anti-angiogenesis therapy.

因此，以这些转录因子为靶标的生物治疗可能是有效的肿瘤抗血管治疗策略。

The rates of systemic and topical side effects in the groups receiving biotherapy were reduced obviously.

生物治疗组全身及局部副反应发生率明显降低（P<0.05）。